Barbara Van Remoortel

1.2k citations

18 papers · 913 indexed · h-index 12

Co-authors: Zeger Debyser Myriam Witvrouw Marc De Maeyer Frauke Christ Belete A. Desimmie Erik De Clercq Arnout Voet Arnaud Marchand
Topics: HIV Research and Treatment (17 papers)HIV/AIDS drug development and treatment (16 papers)Biochemical and Molecular Research (6 papers)
Cited by: Virology Infectious Diseases Molecular Biology
Journals: Journal of Virology The Journal of Infectious Diseases Antimicrobial Agents and Chemotherapy
Partner nations: Belgium Italy South Africa

In The Last Decade

Barbara Van Remoortel

17 papers receiving 890 citations

Peers

Countries citing papers authored by Barbara Van Remoortel

Since Specialization

Citations

This map shows the geographic impact of Barbara Van Remoortel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Van Remoortel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Van Remoortel more than expected).

Fields of papers citing papers by Barbara Van Remoortel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Van Remoortel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Van Remoortel. The network helps show where Barbara Van Remoortel may publish in the future.

Co-authorship network of co-authors of Barbara Van Remoortel

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Van Remoortel. A scholar is included among the top collaborators of Barbara Van Remoortel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Van Remoortel. Barbara Van Remoortel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	CRISPR/Cas9-Induced Mutagenesis Corroborates the Role of Transportin-SR2 in HIV-1 Nuclear Import 2021 ·Microbiology Spectrum ·(unknown),(unknown),(unknown),(unknown),(unknown),Iván Nombela,(unknown),Barbara Van Remoortel,Rik Gijsbers,Frauke Christ,Zeger Debyser	4
2	Analysis of ex vivo HIV-1 infection in a controller-discordant couple 2018 ·Journal of Virus Eradication ·(unknown),(unknown),Barbara Van Remoortel,Sofie Vets,Eric Van Wijngaerden,Kristel Van Laethem,Rik Gijsbers,Rik Schrijvers,Zeger Debyser	2
3	LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions 2013 ·Retrovirology ·Belete A. Desimmie,Rik Schrijvers,Jonas Demeulemeester,Doortje Borrenberghs,(unknown),Wannes Thys,Sofie Vets,Barbara Van Remoortel,Johan Hofkens,Jan De Rijck,Jelle Hendrix,Norbert Bannert,Rik Gijsbers,Frauke Christ,Zeger Debyser	106
4	Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication 2010 ·Nature Chemical Biology ·Frauke Christ,Arnout Voet,Arnaud Marchand,Stefan Nicolet,Belete A. Desimmie,Damien Marchand,Dorothée Bardiot,(unknown),Barbara Van Remoortel,Sergei V. Strelkov,Marc De Maeyer,Patrick Chaltin,Zeger Debyser	369
5	LEDGINs: first-in-class inhibitors of LEDGF/ p75-integrase interaction and HIV replication 2010 ·Lirias (KU Leuven) ·Belete A. Desimmie,Frauke Christ,Arnout Voet,Arnaud Marchand,Stefan Nicolet,Damien Marchand,(unknown),Barbara Van Remoortel,Sergei V. Strelkov,Marc De Maeyer,Patrick Chaltin,Zeger Debyser	3
6	Preclinical Evaluation of 1H-Benzylindole Derivatives as Novel Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors 2008 ·Antimicrobial Agents and Chemotherapy ·Anneleen Hombrouck,Barbara Van Remoortel,Martine Michiels,Wim Noppe,Frauke Christ,(unknown),(unknown),Kurt Benkestock,Lotta Vrang,Nils Gunnar Johansson,Maria Letizia Barreca,Laura De Luca,Stefania Ferro,Alba Chimirri,Zeger Debyser,Myriam Witvrouw	17
7	Mutations in Human Immunodeficiency Virus Type 1 Integrase Confer Resistance to the Naphthyridine L-870,810 and Cross-Resistance to the Clinical Trial Drug GS-9137 2008 ·Antimicrobial Agents and Chemotherapy ·Anneleen Hombrouck,Arnout Voet,Barbara Van Remoortel,(unknown),Marc De Maeyer,Zeger Debyser,Myriam Witvrouw	45
8	Selection of human immunodeficiency virus type 1 resistance against the pyranodipyrimidine V-165 points to a multimodal mechanism of action 2007 ·Journal of Antimicrobial Chemotherapy ·Anneleen Hombrouck,(unknown),Barbara Van Remoortel,(unknown),Jo Vercammen,David Rhodes,Victor Tetz,Yves Engelborghs,Frauke Christ,Zeger Debyser,Myriam Witvrouw	13
9	Mutations in Bothenvandgaggenes are required for HIV-1 resistance to the polysulfonic dendrimer SPL2923, as corroborated by chimeric virus technology 2005 ·Antiviral chemistry & chemotherapy ·(unknown),Valery Fikkert,Barbara Van Remoortel,Christophe Pannecouque,Peter Cherepanov,Barry Matthews,George Holan,Erik De Clercq,Anne–Mieke Vandamme,Zeger Debyser,Myriam Witvrouw	5
10	Is er samenwerking in de thuiszorg ? Evaluatie in het SIT ThuisGezondheidsZorg regio Mortsel 2004 ·(unknown),(unknown),Barbara Van Remoortel,Jan De Lepeleire	0
11	Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360 2004 ·AIDS ·Valery Fikkert,Anneleen Hombrouck,Barbara Van Remoortel,Marc De Maeyer,Christophe Pannecouque,Erik De Clercq,Zeger Debyser,Myriam Witvrouw	63
12	Potent and Selective Inhibition of HIV and SIV by Prostratin Interacting with Viral Entry 2003 ·Antiviral chemistry & chemotherapy ·Myriam Witvrouw,Christophe Pannecouque,Valery Fikkert,(unknown),Barbara Van Remoortel,Marjan Hezareh,Erik De Clercq,Stephen J. Brown	14
13	Development of Resistance against Diketo Derivatives of Human Immunodeficiency Virus Type 1 by Progressive Accumulation of Integrase Mutations 2003 ·Journal of Virology ·Valery Fikkert,Bénédicte Van Maele,Jo Vercammen,(unknown),Barbara Van Remoortel,Martine Michiels,(unknown),Christophe Pannecouque,Marc De Maeyer,Yves Engelborghs,Erik De Clercq,Zeger Debyser,Myriam Witvrouw	80
14	env Chimeric Virus Technology for Evaluating Human Immunodeficiency Virus Susceptibility to Entry Inhibitors 2002 ·Antimicrobial Agents and Chemotherapy ·Valery Fikkert,Peter Cherepanov,Kristel Van Laethem,(unknown),Barbara Van Remoortel,Christophe Pannecouque,Erik De Clercq,Zeger Debyser,Anne–Mieke Vandamme,Myriam Witvrouw	33
15	Chimeric virus technology (CVT) for HIV env-genes to evaluate the resistance/susceptibility profile towards HIV entry inhibitors 2002 ·(unknown),Peter Cherepanov,Kristel Van Laethem,(unknown),Barbara Van Remoortel,Christophe Pannecouque,Erik De Clercq,Zeger Debyser,Anne–Mieke Vandamme,Myriam Witvrouw	2
16	Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype 2001 ·AIDS ·Kristel Van Laethem,Myriam Witvrouw,Christophe Pannecouque,Barbara Van Remoortel,Jean‐Claude Schmit,Robert Esnouf,Jőrg‐Peter Kleim,Jan Balzarini,Jan Desmyter,Erik De Clercq,Anne–Mieke Vandamme	16
17	Cell Type-Dependent Effect of Sodium Valproate on Human Immunodeficiency Virus Type 1 Replication in Vitro 1997 ·AIDS Research and Human Retroviruses ·Myriam Witvrouw,Jean‐Claude Schmit,Barbara Van Remoortel,Dirk Daelemans,José A. Esté,Anne–Mieke Vandamme,Jan Desmyter,Erik De Clercq	29
18	Multiple Drug Resistance to Nucleoside Analogues and Nonnucleoside Reverse Transcriptase Inhibitors in an Efficiently Replicating Human Immunodeficiency Virus Type 1 Patient Strain 1996 ·The Journal of Infectious Diseases ·Jean‐Claude Schmit,Jacqueline Cogniaux,P. Hermans,(unknown),S Sprecher,Barbara Van Remoortel,Myriam Witvrouw,Jan Balzarini,Jan Desmyter,Erik De Clercq,Anne–Mieke Vandamme	112

About Barbara Van Remoortel

Barbara Van Remoortel is a scholar working on Virology, Infectious Diseases and Molecular Biology, having authored 18 papers that have together received 913 indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (16 papers) and Biochemical and Molecular Research (6 papers). The work is most often cited by research in Virology (745 citations), Infectious Diseases (735 citations) and Molecular Biology (434 citations). Barbara Van Remoortel has collaborated with scholars based in Belgium, Italy and South Africa. Frequent co-authors include Zeger Debyser, Myriam Witvrouw, Marc De Maeyer, Frauke Christ, Belete A. Desimmie, Erik De Clercq, Arnout Voet, Arnaud Marchand, Patrick Chaltin and Damien Marchand. Their work appears in journals such as Journal of Virology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact